CancerTrack Cancer Monitoring Test
CancerTrack™ Cancer Monitoring Test from Datar Cancer Genetics is a non-invasive blood based investigation that detects cancer derived biomarkers with ultra-high precision, specificity and reliability. CancertrackTM can be used to monitor the disease /recurrence or changes in the tumor characteristics, as often as necessary, without the cost, risk and consequences of radiation from scans, hospitalisation, anaesthesia or painful surgical biopsies.
Who is the CancerTrack Cancer Monitoring Test for?
- Anybody who has a newly diagnosed cancer as a supplement to normal biopsy to provide a baseline measurement of cell-free tumour DNA and CTC before starting treatment
- Anybody who has cancer and is having cancer treatment
- Anybody who has had cancer and in cancer remission
- Anybody who has had cancer in the past and is a cancer survivor
Optimally by monitoring for early signs of recurrence or changes in the cancer, the treatment is always one step ahead of the cancer. Cancertrack™ ensures real-time monitoring to detect genetic changes in the tumor at an early stage. Clinically relevant mutations can thereby be monitored, or medication can be changed if necessary.
In the event of a positive/ actionable result then follow up investigations or therapy may be required. These may not be covered by the NHS or health insurance providers and so as a support, Datar Cancer Genetics can provide an oncologist at a separate cost if necessary.